Effect of sequential chemotherapy and gefitinib on survival outcome in advanced NSCLC with acquired gefitinib resistance.

Huijuan Wang(Beijing Chao-Yang Hospital, Capital Medical University), Ma Yong(Henan Cancer Hospital), Wei Zhang(Zhejiang Chinese Medical University), Mina Zhang(Shanghai University of Traditional Chinese Medicine), Hui Zhu(Sun Yat-sen University), Shaomei Li(Huazhong Agricultural University), Li Peng(University of North Carolina at Chapel Hill)
Journal of Clinical Oncology
May 20, 2013
Cited by 0


Related Papers